Our renowned physicians deliver the best in compassionate patient care, offering extensive experience to people with memory disorders.
All patients receive thorough diagnostic evaluations to identify and classify memory problems or disorders. The most advanced analytic tests, including neuropsychological testing, DNA and plasma evaluations, magnetic resonance imaging (MRI), and positron emission tomography (PET) scans provide a roadmap for treatment.
Our Alzheimer's Disease Center (ADC) is one of 32 institutions funded by the National Institutes of Health’s National Institute on Aging. More than 150 new patients a year are evaluated at the ADC, and our database includes information on more than 2,500 patients treated since 1988.
Memory disorders treated at the clinic include:
Our clinic enrolls a large number of patients in cognitive-related observational and clinical trials underway at UT Southwestern Medical Center.
We enroll and conduct yearly evaluations of people who do not have any significant symptoms of cognitive impairment. These studies allow us to learn about the changes that occur normally in aging, and to make important comparisons of normal versus abnormal aging brain function.
We enroll patients who have mild cognitive impairment, meaning that the person has consistent problems with memory or another area of cognition but does not have noticeable impairment in daily functioning.
Participants with dementia are enrolled to help us answer a number of important research questions regarding early symptoms, risk factors, genetics, imaging, treatment, dietary, and environmental factors possibly related to mild Alzheimer’s disease, frontotemporal dementia, etc.
Clinical trials are carefully controlled studies of new and emerging diagnostics and treatments. These trials bring state-of-the art knowledge to patient diagnosis and care. Some studies focus on treatment of memory and thinking problems, some on behavioral and mood disturbance, and others on prevention.
We have studies investigating new imaging techniques and medications for the treatment of all stages of dementia. These studies may involve specific vitamin therapy, the use of already approved medications for a new use, the use of investigational combinations of medications, as well as newly developed medications that are not yet FDA-approved or available to the public.